Newamsterdam Pharma Company N V Revenue per Employee (NAMS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Newamsterdam Pharma Company N v   (NASDAQ: NAMS)
 

Newamsterdam Pharma N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 2.08% in the first quarter 2026, year on year to cumulative value of $23 million, Newamsterdam Pharma N V 's revenue per employee grew on a trailing twelve months basis to $ 225,650, this is below the company average.
Within the Healthcare sector Employees of 231 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1813, from total ranking in previous quarter at 2161. Newamsterdam Pharma N V has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NAMS Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change 2.08 % -99.75 % -98.8 % 740.06 % 112.56 %
Sales per Employee (TTM) $ 225,650 225,030 352,430 640,060 471,400
NAMS's Total Ranking # 1813 # 2161 # 1028 # 1357 # 1633
Seq. Revenue Change 9400 % -90.8 % -98.18 % 542.88 % -76.68 %

NAMS Company Profile >> Back to NAMS Efficiency Comparisons >> Compare NAMS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 232
Overall Market # 1813

Revenue per Employee Statistics
High Average Low
$ 640,060 $ 395,033 $ 225,030
(Jun 30 2025)   (Dec 31 2025)



Financial Statements
Newamsterdam Pharma N V 's Revenue MRQ $ 3 Millions Visit NAMS's Income Statement
Newamsterdam Pharma N V 's Revenues TTM $ 23 Millions Visit NAMS's aggregate revenue growth
What are NAMS's Sales? Visit NAMS's Sales by Segment




Other Ratios
Newamsterdam Pharma N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NAMS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NAMS's Competitors
Revenue per Employee for NAMS's Suppliers
Revenue per Employee for NAMS's Customers

You may also want to know
NAMS's Sales Growth Rates NAMS's Pe Price to earnings ratio NAMS's Receivables Turnover Ratio NAMS's Stock Quote
NAMS's Net Income Growth Rates NAMS's Ps Price to Sales ratio NAMS's Sales per Employee NAMS's Asset Turnover Ratio
NAMS's Net Margin NAMS's Pb Price to Book ratio NAMS's Financial Strength Ratios NAMS's Dividend Payout Ratio
Date modified: 2026-07-07T12:17:48+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Edwards Lifesciences Corporation  393,956.25 $ 6,303.300  Million 16,000 
Arcus Biosciences Inc   392,678.87 $ 236.000  Million 601 
Abbott Laboratories  392,469.57 $ 45,134.000  Million 115,000 
Lemaitre Vascular Inc   391,625.95 $ 256.515  Million 655 
Nrc Health  388,352.94 $ 138.642  Million 357 
Edap Tms Sa  387,941.18 $ 112.115  Million 289 
Castle Biosciences Inc   384,960.36 $ 339.920  Million 883 
Lensar Inc   384,693.33 $ 57.704  Million 150 
Axogen inc   382,805.47 $ 238.105  Million 622 
Sensus Healthcare Inc   381,783.33 $ 22.907  Million 60 
Repligen Corp  381,669.50 $ 763.339  Million 2,000 
Orchestra Biomed Holdings Inc   380,511.63 $ 32.724  Million 86 
Outset Medical Inc   376,719.35 $ 116.783  Million 310 
Xencor Inc  374,461.54 $ 97.360  Million 260 
Kewaunee Scientific Corporation  371,649.01 $ 280.595  Million 755 
Integra Lifesciences Holdings Corp  371,472.78 $ 1,644.510  Million 4,427 
Lftd Partners Inc   369,551.55 $ 36.955  Million 100 
Tela Bio Inc   368,573.39 $ 80.349  Million 218 
Logicmark Inc  365,090.03 $ 12.048  Million 33 
Amphastar Pharmaceuticals Inc   364,640.69 $ 720.530  Million 1,976 
Precipio inc   363,816.90 $ 25.831  Million 71 
Arvinas Inc   363,414.63 $ 89.400  Million 246 
Msa Safety Inc  361,754.53 $ 1,917.299  Million 5,300 
Procept Biorobotics Corporation  361,500.00 $ 321.012  Million 888 
Nutriband Inc   360,523.60 $ 1.803  Million 5 
Rosecliff Acquisition Corp I  360,507.69 $ 23.433  Million 65 
Amneal Pharmaceuticals Inc   358,297.65 $ 3,045.530  Million 8,500 
Electromed Inc   357,756.35 $ 70.478  Million 197 
Maxcyte inc   354,802.20 $ 32.287  Million 91 
Conmed Corporation  351,413.85 $ 1,370.514  Million 3,900 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.